(NEW YORK)Drug developers King Pharmaceuticals Inc. and Pain Therapeutics Inc. will likely gain Food and Drug Administration approval of their abuse-resistant pain killer, but sales potentia...READ MORE

(CUPERTINO, Calif.)Drug developer Durect Corp. said Monday its third-quarter loss increased 16 percent, as the company ramped up spending to work on its drug candidates.READ MORE

(BRIDGEWATER, N.J.)Specialty pharmaceutical company Alpharma Inc. raised the low end of its 2008 profit forecast Wednesday, pointing to its 30 percent revenue growth in the third quarter.READ MORE

(SAN MATEO, Calif.)Pain Therapeutics Inc. said Tuesday it received $20 million from partner King Pharmaceuticals Inc. as regulators review a pair of abuse-resistant pain drug candidates the companies...READ MORE

(CUPERTINO, Calif.)Drug developer Durect Corp. said Tuesday it applied for regulatory approval of Remoxy, designed to be an abuse-resistant form of oxycodone. The company submitted a new drug applica...READ MORE

(NEW YORK)Shares of drug developer Durect Corp. surged Thursday, after the company reported a smaller first-quarter loss on lower costs and greater research and development partnership reven...READ MORE

Among the earnings stories for Wednesday, May 7, from AP Financial News: CUPERTINO, Calif. (AP) _ Pharmaceutical company Durect Corp. said Wednesday its loss narrowed in the first ...READ MORE